Breaking Research News from Breastcancer.org

Moderators

ASCO Issues Guidelines on Treatments for Advanced-Stage HER2-Negative Breast Cancer
September 4, 2014
The American Society of Clinical Oncology has put out new guidelines on
treating women diagnosed with advanced-stage HER2-negative breast
cancer. Read more...

Moderators

Complications Uncommon After Single or Double Mastectomy
September 5, 2014
Complications are uncommon after single or double mastectomy and
immediate reconstruction, though women who had double mastectomy did
have more complications than women who had single mastectomy. Read more...

Moderators

Eating Soy May Turn on Genes Linked to Cancer Growth
September 5, 2014
Study suggests that for some women adding a medium amount of soy to their diets turns on genes that can cause cancer to grow. Read more...

Moderators

Lumpectomy Plus Radiation May Offer Survival Benefits Over Mastectomy for Early-Stage, Hormone-Receptor-Positive Disease
September 9, 2014
A study suggests that women diagnosed with stage I
hormone-receptor-positive breast cancer who have lumpectomy followed by
radiation have better survival rates than women who have mastectomy
alone or lumpectomy alone. Read more...

Moderators

Trelstar May Help Increase Pregnancy Chances After Chemo
September 9, 2014
Women diagnosed with early-stage breast cancer who were treated with
Trelstar in addition to chemotherapy might find it easier to get
pregnant after chemotherapy ends, but the results weren’t definitive. Read more...

Moderators

Study Confirms No Link Between Wearing a Bra and Breast Cancer Risk
September 9, 2014
More research confirms that wearing a bra doesn’t increase breast cancer risk. Read more...

cfdr

A nutritionist that gave a workshop at a "cancer camp" I attended said that the problem with soy is not an issue when it is eaten as a whole food, but when it is processed into soy protein islolate and given as a supplement. So it's not clear to me from this study if eating tofu is truly a danger.

tgtg

Cdfr--Here are three factoids not included in the study that might address your question:  

1) Japanese women eat lots of real soy--think edamame, tofu, and natto--because meat is so expensive there.

2) Japanese women do not use soy powders or processed soy other than soya (soy sauce).

3) Japan has a really low incidence of breast cancer.  (They also eat lots of vegetables there.)

So it seems to me that the real thing is most definitely not a danger to women in Japan (including my daughter-in-law and her female relatives!  Grandma Iwasawa is still cancer-free after 90 + years of eating soy!  

cfdr

tgtg, I've read things along those lines as well. Also edited my original post to include complete sentences that make sense...I should not post before I've had my coffee. :-p

Moderators

Most Women Who Have Healthy Breast Removed Preventively Happy With Decision
September 26, 2014
A study suggests that most women who have contralateral prophylactic
mastectomy have no regrets and would make the same choice again. Read more...

Moderators

Perjeta Boosts Overall Survival in HER2-Positive Metastatic Breast Cancer
September 30, 2014
Final results from the CLEOPATRA study showed that women diagnosed with
HER2-positive metastatic breast cancer who got Perjeta, Herceptin, and
Taxotere lived about 1.5 years longer than women who got only Herceptin
and Taxotere. Read more...

Moderators

More Evidence That Breastfeeding Reduces Hormone-Receptor-Negative Breast Cancer Risk in Black Women
October 2, 2014
Results from a large study underscore earlier research strongly
suggesting that black women who breastfeed have a lower risk of
hormone-receptor-negative and triple-negative breast cancer. Read more...

Moderators

International Panel Issues Guidelines for Managing Advanced-Stage Breast Cancer
October 2, 2014
The European School of Oncology and the European Society of Medical
Oncology have put out new guidelines on treating advanced-stage breast
cancer. Read more...

Moderators

Metastatic Breast Cancer Alliance Releases Landscape Analysis of Metastatic Disease
October 13, 2014
The Metastatic Breast Cancer Alliance has released a new report on the state of metastatic breast cancer. Read more...

Moderators

Cancer Found in More Than 2% of High-Risk Women Who Have Ovaries Removed Preventively
October 14, 2014
More than 2% of women at high-risk for ovarian cancer because of
genetics or family history who had their ovaries and fallopian tubes
removed preventively had cancer that was found during ovary removal
surgery. Read more...

Moderators

Cancer’s Response to Chemotherapy Before Surgery May Help Predict Risk of Recurrence
October 15, 2014
Researchers find that certain factors, including cancer characteristics,
can help predict the risk of cancer coming back in the breast area
after neoadjuvant chemotherapy. Read more...

Moderators

Study Shows Herceptin Offers Long-Lasting Benefits for Early-Stage, HER2-Positive Disease
October 28, 2014
Results from an analysis of two large, long-term studies show that
adding Herceptin to chemotherapy to treat women diagnosed with
early-stage HER2-positive breast cancer improves overall survival and
disease-free survival compared to chemotherapy alone. Read more...

Moderators

Genomic Test Helps Estimate Risk of Recurrence More Than 5 Years After Diagnosis for Some Breast Cancers
October 29, 2014
The Prosigna genomic test can help predict the risk of distant
recurrence for early-stage hormone-receptor-positive breast cancer after
5 years of hormonal therapy treatment in postmenopausal women. Read more...

Moderators

Genetic Variant Lowers Breast Cancer Risk for Some Latina Women
October 31, 2014
Research suggests that a genetic variant in some Latina women may reduce breast cancer risk by 40% to 80%. Read more...

Moderators

Strength After Breast Cancer Exercise Program Successful in Real-Life Setting
November 6, 2014
A study has found that the Strength After Breast Cancer program, an education and gradual exercise program, can be successfully implemented in a larger, real-world setting. The study also found certain factors that could make the program less successful and offered solutions. Read more...

Moderators

Electroacupuncture Helps Ease Joint Pain From Aromatase Inhibitors, Especially if Women Believe it Works
November 6, 2014
A study has found that women who expect placebo electroacupuncture to work get better pain relief than women who expect the treatment to work and get real electroacupuncture. Read more...

Moderators

Experimental Targeted Therapy May Help Treat People With Advanced-Stage Cancer Due to Abnormal BRCA Gene
November 7, 2014
A study found that more than 25% of people with an abnormal BRCA1 or BRCA2 gene being treated for advanced-stage breast, ovarian, pancreatic, or prostate cancer got some benefit from olaparib, an experimental targeted therapy medicine. Read more...

Moderators

Society for Integrative Oncology Issues Guidelines on Complementary Therapies
November 11, 2014
To help doctors and patients understand which complementary therapies are safe and effective for people diagnosed with breast cancer, the Society for Integrative Oncology has published guidelines. Read more...

Moderators

About 25% of Women Need More Surgery After Lumpectomy
November 13, 2014
A study has found that about 25% of women who have lumpectomy have to have more surgery once their doctors have all the information about the cancer and breast tissue that was removed. Read more...

Moderators

More U.S. Women Choosing Mastectomy Over Lumpectomy for Early-Stage Disease
November 21, 2014
In the past 10 years, more U.S. women diagnosed with early-stage breast cancer who were eligible for lumpectomy chose mastectomy or double mastectomy followed by reconstruction. Read more...

Moderators

Common Blood Pressure Medicine Doesn't Increase Breast Cancer Risk
November 21, 2014
In contrast to a study released in 2013, a new, larger study suggests that calcium channel blockers don't increase the risk of breast cancer. Read more...

Moderators

Screening Based on Risk for Women in Their 40s Likely Misses Most Breast Cancers
December 5, 2014
A small study suggests that more than 75% of women ages 40 to 49 diagnosed with breast cancer didn't meet the criteria for risk-based screening. Read more...

Moderators

Device That Standardizes Pressure During Mammograms Could Reduce Pain
December 9, 2014
A device that allows technicians to know the pressure being applied to the breast during a mammogram can reduce pain without affecting the quality of the image or the amount of radiation absorbed. Read more...

Moderators

Study Suggests Earlier Research on CYP2D6 Is Flawed
December 11, 2014
A study by researchers at the Mayo Clinic suggests that the large studies on the link between CYP2D6 and tamoxifen's effectiveness may be flawed because the studies did the genetic testing on samples of tissue from the breast cancer rather than on healthy tissue. Read more...

Moderators

Aromasin Plus Ovarian Suppression Reduces Recurrence Risk Better Than Tamoxifen Plus Ovarian Suppression in Premenopausal Women Who've Received Chemotherapy (with video)
December 11, 2014
Watch an interview with Prudence Francis, M.D., lead author of the SOFT study, which suggests that Aromasin plus ovarian suppression reduces the risk of recurrence more than tamoxifen plus ovarian suppression in premenopausal women diagnosed with early-stage hormone-receptor-positive breast cancer that's been treated with chemotherapy. Read more...